Go offline with the Player FM app!
Finding a CURE for rare genetic disorders
Manage episode 495011449 series 3529081
Get ready for one of our most meaningful conversations yet. Dr. Chloe sits down with Elizabeth DeLuca—the powerhouse advocate whose late-night PubMed searches, cross-country lab visits, and “help-the-babies” fund-raising campaigns helped push Capsida’s CAP-002 gene-therapy program all the way to FDA clearance. We unpack how this first-in-human trial aims to restore the missing STXBP1 protein, why the same technology could leapfrog into other rare epilepsies, and how a mother’s promise to her daughter is changing the face of science.
Quick links
- Capsida CAP-002 press release – details on the FDA-cleared trial and how it works:
- https://capsida.com/capsida-receives-fda-ind-clearance-for-its-first-in-class-iv-administered-gene-therapy-for-stxbp1-developmental-and-epileptic-encephalopathy/ capsida.com
- STXBP1 Foundation – join the registry, learn about natural-history studies, or donate:
- https://www.stxbp1disorders.org/ STXBP1 Foundation
- Support our mission by shopping the herbal lines that fund this podcast and Remy’s ongoing care:
- • Radical Roots Herbs – whole-plant, spagyric CBD formulas: https://RadicalRootsHerbs.com
- • Noxi Herbs – modular Chinese-herb system for women’s hormones: https://NoxiHerbs.com
Heads-up: We speak candidly about seizures, neuro-degeneration, and child loss. Estimated annual mortality for STXBP1 remains ~3 %—every child is one too many—and that stark reality fuels Elizabeth’s drive and Dr. Chloe’s daily fight for her son, Remy.
Listen, share, and stand with the rare-disease community that defines our world.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
37 episodes
Manage episode 495011449 series 3529081
Get ready for one of our most meaningful conversations yet. Dr. Chloe sits down with Elizabeth DeLuca—the powerhouse advocate whose late-night PubMed searches, cross-country lab visits, and “help-the-babies” fund-raising campaigns helped push Capsida’s CAP-002 gene-therapy program all the way to FDA clearance. We unpack how this first-in-human trial aims to restore the missing STXBP1 protein, why the same technology could leapfrog into other rare epilepsies, and how a mother’s promise to her daughter is changing the face of science.
Quick links
- Capsida CAP-002 press release – details on the FDA-cleared trial and how it works:
- https://capsida.com/capsida-receives-fda-ind-clearance-for-its-first-in-class-iv-administered-gene-therapy-for-stxbp1-developmental-and-epileptic-encephalopathy/ capsida.com
- STXBP1 Foundation – join the registry, learn about natural-history studies, or donate:
- https://www.stxbp1disorders.org/ STXBP1 Foundation
- Support our mission by shopping the herbal lines that fund this podcast and Remy’s ongoing care:
- • Radical Roots Herbs – whole-plant, spagyric CBD formulas: https://RadicalRootsHerbs.com
- • Noxi Herbs – modular Chinese-herb system for women’s hormones: https://NoxiHerbs.com
Heads-up: We speak candidly about seizures, neuro-degeneration, and child loss. Estimated annual mortality for STXBP1 remains ~3 %—every child is one too many—and that stark reality fuels Elizabeth’s drive and Dr. Chloe’s daily fight for her son, Remy.
Listen, share, and stand with the rare-disease community that defines our world.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
37 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.